<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Caspian Journal of Internal Medicine</title>
<title_fa></title_fa>
<short_title>Caspian J Intern Med</short_title>
<subject>Medical Sciences</subject>
<web_url>http://caspjim.com</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>2008-6164</journal_id_issn>
<journal_id_issn_online>2008-6172</journal_id_issn_online>
<journal_id_pii>8</journal_id_pii>
<journal_id_doi>10.22088/cjim</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid>14</journal_id_sid>
<journal_id_nlai>8888</journal_id_nlai>
<journal_id_science>13</journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1400</year>
	<month>10</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2022</year>
	<month>1</month>
	<day>1</day>
</pubdate>
<volume>13</volume>
<number>1</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Ocular Manifestation in a patient with IgG4 Related Disease</title>
	<subject_fa>Reumatology</subject_fa>
	<subject>Reumatology</subject>
	<content_type_fa>case report</content_type_fa>
	<content_type>case report</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;span style=&quot;font-size:14px;&quot;&gt;&lt;span style=&quot;font-family:Times New Roman;&quot;&gt;&lt;span style=&quot;color:#0000ff;&quot;&gt;&lt;strong&gt;&lt;em&gt;Background&lt;/em&gt;&lt;/strong&gt;&lt;em&gt;:&lt;/em&gt;&lt;/span&gt; IgG4-related disease is a newly recognized fibroinflammatory disease presenting with multiple features including mass forming lesion; a dense lymphoplasmacytic infiltrate; a characteristic histopathological appearance and often elevated serum of IgG4. This disease can potentially affect any organ and interestingly, the affected organs share common histopathological features including a dense lymphoplasmacytic infiltrate rich in IgG4-positive plasma cells, storiform fibrosis, and mild to moderate eosinophilia&lt;br&gt;
&lt;span style=&quot;color:#0000ff;&quot;&gt;&lt;strong&gt;&lt;em&gt;Case Presentation:&lt;/em&gt;&lt;/strong&gt;&lt;/span&gt; A&amp;nbsp;45-year-old&amp;nbsp;man presented complaining of proptosis and gradual decrease in visual acuity of right eye. He had undergone many work-ups but without any definitive diagnosis. Through a combination of clinical and para-clinical investigations, the diagnosis of IgG4-RD was established. 693 mg/dL). Aggressive treatment (pulse of cyclophosphamide and pulse of corticosteroid) was started hoping to save the patient&amp;rsquo;s vision. Two weeks following the treatment, there was improvement with his visual acuity and proptosis.&lt;br&gt;
&lt;span style=&quot;color:#0000ff;&quot;&gt;&lt;strong&gt;&lt;em&gt;Conclusion&lt;/em&gt;&lt;/strong&gt;&lt;em&gt;:&lt;/em&gt;&lt;/span&gt; In any patient with chronic tumor like lesions and pseudotumors without the evidence of malignancy, we should think of IgG4-related disease. In this circumstance, biopsy may lead us to the definitive diagnosis. Early diagnosis and treatment of IgG4-RD may inhibit further irreversible organ damages.&lt;/span&gt;&lt;/span&gt;</abstract>
	<keyword_fa></keyword_fa>
	<keyword>IgG4-related disease, IgG4-related orbitopathy, visual acuity, Proptosis.</keyword>
	<start_page>127</start_page>
	<end_page>131</end_page>
	<web_url>http://caspjim.com/browse.php?a_code=A-10-1402-3&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Samaneh</first_name>
	<middle_name></middle_name>
	<last_name>Azizianesh</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>sam.medicin84@gmail.com</email>
	<code>100319475328460033359</code>
	<orcid>100319475328460033359</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Research Center for Rheumatologic Diseases, Amir-Alam Hospital, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Fatema </first_name>
	<middle_name></middle_name>
	<last_name>Rizvi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>fateme.sadaat1@gmail.com</email>
	<code>100319475328460033360</code>
	<orcid>100319475328460033360</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>School of medicine, Tehran University of Medical Science, Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Hamed</first_name>
	<middle_name></middle_name>
	<last_name>Zainaldain</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>Hamed.hadi@aol.com</email>
	<code>100319475328460033361</code>
	<orcid>100319475328460033361</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>School of medicine, Tehran University of Medical Science, Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Samira</first_name>
	<middle_name></middle_name>
	<last_name>Alesaeidi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>ahmad.23088@gmail.com</email>
	<code>100319475328460033362</code>
	<orcid>100319475328460033362</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Department of Rheumatology, Amir-Alam Hospital, Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
